BeOne Medicines
Price & Volume
Stats
See more52W Range | $253.94-$410.71 |
Market Cap | $46.4B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $6.6B |
Revenue Growth (YoY) | 33.8% |
Gross Profit (12 Mos) | $5.9B |
Diluted EPS | $7.80 |
News
See moreYahoo Finance • 2 days ago
Top 3 Healthcare Stocks To Watch In November 2026
Yahoo Finance • 4 days ago
Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?
Yahoo Finance • 5 days ago
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma
Yahoo Finance • 17 days ago
BeOne Stock Tests Buy Zone With Visions Of 177% Earnings Growth. Watch This Clue.
About
CEO | Mr. John V. Oyler |
Address | 94 Aeschengraben 27, Basel, Switzerland, 4051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12,000 |